Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05877066 · ClinicalTrials.gov registry record
Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture
A clinical trial, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
- Terminated
- Registry status
- 130
- Enrollment target
NCT05877066: Clinical Trial study, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
NCT05877066 is a clinical trial that was terminated before completion, run by Endo USA Inc., a Keenova Therapeutics Company. The registered enrollment target is 130 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05877066 was terminated before completion, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
- TERMINATED
- Registry status
- 130 participants
- Enrollment target
Study Summary
This is an observational study, meaning participants will not receive any investigational treatment as part of this study. Researchers will collect real-world data (RWD), based on usual care, to gain a more in-depth knowledge of the natural history and the treatment outcomes of Dupuytren's Contracture (DC) to evaluate the management of DC.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2023-06-14 |
| Est. Completion | 2024-02-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05877066
The ClinicalTrials.gov registry entry for NCT05877066 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endo USA Inc., a Keenova Therapeutics Company, which has 61 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05877066 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05877066 about?
NCT05877066 is a clinical study titled "Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture". This is an observational study, meaning participants will not receive any investigational treatment as part of this study. Researchers will collect real-world data (RWD), based on usual care, to gain a more in-depth knowledge of the natural history and the treatment outcomes of Dupuytren's Contract...
What is the current status of trial NCT05877066?
This trial is currently terminated. The enrollment target is 130 participants. The study started on 2023-06-14. Estimated completion is 2024-02-26.
Who is sponsoring clinical trial NCT05877066?
This trial is sponsored by Endo USA Inc., a Keenova Therapeutics Company, which has 61 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.